| Heading: |
Estradiol |
| Question ID: |
1798001 |
| UIN: |
48638 |
| House: |
Commons |
| Date tabled: |
2025-04-28 |
| Asking Member ID: |
5090 |
| Asking Member display name: |
Tom Morrison
|
| Asking Member handle: |
thomasmorrison
|
| Asking Member Twitter reference: |
@thomasmorrison
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what guidance he has provided to (a) GPs and (b) pharmacists to support patients unable to access Estradot patches. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-05-06 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
There are over 70 hormone replacement therapy (HRT) products, and the vast majority are in good supply. Previously there have been issues with the supply of a limited number of these products, primarily driven by very sharp increases in demand. Following ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |